Novartis Institutes for Biomedical Research
Dr. Erik Scalfaro is affiliated to Patient Safety, Novartis Institutes for Biomedical Research. Dr. Erik Scalfaro is currently providing services as Professor. Dr. Erik Scalfaro has authored and co-authored multiple peer-reviewed scientific papers and presented works at many national and International conferences. Dr. Erik Scalfaro contributions have acclaimed recognition from honourable subject experts around the world. Dr. Erik Scalfaro is actively associated with different societies and academies. Dr. Erik Scalfaro academic career is decorated with several reputed awards and funding. Dr. Erik Scalfaro research interests include Patient Safety.
Imidazo[1,2-a]pyridin-6-yl-benzamide analogs as potent RAF inhibitors.